NULL

Posted 8th January 2016 • 1 min read
Strategic Partnership and Optional Merger Agreement to Develop Antibody Drug Conjugates and Bi-Speci
Zymeworks Inc. and Kairos Therapeutics Inc., both privately-held biotech companies headquartered in Vancouver, announced today they have entered into a strategic partnership.
Strategic Partnership and Optional Merger Agreement to Develop Antibody Drug Conjugates and Bi-Speci
Our Trusted Brands
Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.